212 related articles for article (PubMed ID: 36858863)
1. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
2. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
[TBL] [Abstract][Full Text] [Related]
3. Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature.
Karvigh SA; Salehizadeh S; Vahabizad F
J Med Case Rep; 2022 Nov; 16(1):409. PubMed ID: 36348436
[TBL] [Abstract][Full Text] [Related]
4. Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report.
Hou L; Wan L; Li H; Wang Z; Guan H; Ren H; Wang P
BMC Neurol; 2022 Jul; 22(1):281. PubMed ID: 35896991
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
6. Bi-Basal Ganglia Involvement with Signal Evolution in a Case of Anti-LGI1 Encephalitis.
Gai Q; Ruan S; Dong X; Cong S
Neurol India; 2022; 70(1):384-386. PubMed ID: 35263922
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
Chen L; Su T; Liu Y
BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
[TBL] [Abstract][Full Text] [Related]
9. A Chinese female patient with LGI1 and mGluR5 antibodies: A case report.
Huo T; Luo X; Zhao J; Wang T; Chen J
Medicine (Baltimore); 2022 Oct; 101(43):e31063. PubMed ID: 36316880
[TBL] [Abstract][Full Text] [Related]
10. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
[TBL] [Abstract][Full Text] [Related]
11. What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
Li C; Cai HB; Zhao X; Xi XC; Zhou Q; Luo HY; Tang ZP; Kang HC; Kirsch HE
Eur Neurol; 2022; 85(6):437-445. PubMed ID: 35896086
[TBL] [Abstract][Full Text] [Related]
12. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
Li Z; Cui T; Shi W; Wang Q
Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
[TBL] [Abstract][Full Text] [Related]
13. Anti-LGI1 encephalitis: A family affair.
De Stefano G; Pulitano P; Di Bonaventura C; Zuliani L; Morano A
J Neuroimmunol; 2023 May; 378():578084. PubMed ID: 37037125
[TBL] [Abstract][Full Text] [Related]
14. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
[TBL] [Abstract][Full Text] [Related]
15. Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report.
Adhikari A; Subedi RC; Acharya S; Paudel R
JNMA J Nepal Med Assoc; 2020 Jul; 58(227):487-490. PubMed ID: 32827010
[TBL] [Abstract][Full Text] [Related]
16. Confusion and Hallucination in a Geriatric Patient. Pitfalls of a Rare Differential: Case Report of an Anti-LGI1-Encephalitis.
Meier L; Weinrebe W; Annoni JM; Petersen JA
Clin Interv Aging; 2022; 17():1423-1432. PubMed ID: 36187571
[TBL] [Abstract][Full Text] [Related]
17. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
[TBL] [Abstract][Full Text] [Related]
18. Leucine-Rich Glioma-Inactivated 1 Encephalitis: Broadening the Sphere.
Rachdi A; Dupouy J; Benaiteau M; Bost C; Moreau MS; Courbon CB; Rascol O; Magne FO
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31656690
[TBL] [Abstract][Full Text] [Related]
19. A Case of Anti-Leucine-Rich Glioma-Inactivated Protein 1 (Anti-LGI1) Limbic Encephalitis With New-Onset Panic Attacks.
Coleman B; Sawhney K; LaPenna P
Cureus; 2024 Apr; 16(4):e58406. PubMed ID: 38756253
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis.
Qiao T; Chen L; Jiang L; Wei H; Chen X; Li X; Chen Y; Xu Y
Front Immunol; 2022; 13():986853. PubMed ID: 36211373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
